- Home
- ONL vs IPA Comparison
ONL vs IPA Comparison
Compare ONL & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- IPA
- Stock Information
- Founded
- ONL 2021
- IPA 1983
- Country
- ONL United States
- IPA United States
- Employees
- ONL N/A
- IPA N/A
- Industry
- ONL Real Estate Investment Trusts
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- ONL Real Estate
- IPA Health Care
- Exchange
- ONL Nasdaq
- IPA Nasdaq
- Market Cap
- ONL 119.7M
- IPA 98.9M
- IPO Year
- ONL N/A
- IPA 2017
- Fundamental
- Price
- ONL $2.97
- IPA $2.37
- Analyst Decision
- ONL Hold
- IPA Strong Buy
- Analyst Count
- ONL 1
- IPA 2
- Target Price
- ONL N/A
- IPA $4.00
- AVG Volume (30 Days)
- ONL 354.0K
- IPA 1.7M
- Earning Date
- ONL 08-06-2025
- IPA 09-15-2025
- Dividend Yield
- ONL 2.69%
- IPA N/A
- EPS Growth
- ONL N/A
- IPA N/A
- EPS
- ONL N/A
- IPA N/A
- Revenue
- ONL $151,869,000.00
- IPA $17,744,713.00
- Revenue This Year
- ONL N/A
- IPA $18.76
- Revenue Next Year
- ONL N/A
- IPA $32.14
- P/E Ratio
- ONL N/A
- IPA N/A
- Revenue Growth
- ONL N/A
- IPA 0.01
- 52 Week Low
- ONL $1.46
- IPA $0.27
- 52 Week High
- ONL $4.39
- IPA $3.25
- Technical
- Relative Strength Index (RSI)
- ONL 75.51
- IPA 52.50
- Support Level
- ONL $2.52
- IPA $2.59
- Resistance Level
- ONL $2.85
- IPA $3.25
- Average True Range (ATR)
- ONL 0.10
- IPA 0.33
- MACD
- ONL 0.02
- IPA -0.02
- Stochastic Oscillator
- ONL 91.26
- IPA 38.78
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.